Adipotide (FTPP) 10mg

$89.00

& Free Shipping

Adipotide, also known as FTPP, is a synthetic peptidomimetic designed to target specific vascular markers associated with white adipose tissue. Adipotide peptide research focuses on its ability to bind receptors expressed in adipose-associated endothelial cells and induce apoptosis within those vascular structures under controlled experimental conditions. Structurally, it is a cyclic peptide linked to a proapoptotic sequence, allowing investigators to study tissue-selective vascular targeting mechanisms in laboratory models.

Research is primarily conducted in cell-based systems and animal models to evaluate endothelial cell apoptosis, vascular density changes, and downstream effects on adipose tissue mass. Major areas of investigation include adipose tissue vascular biology, angiogenesis-related signaling pathways, and metabolic marker shifts observed in preclinical systems. These biological systems are important in laboratory research because they provide measurable endpoints for studying targeted vascular modulation and tissue remodeling without implying human therapeutic application.

For research use only. Not for human consumption.

References:
Barnhart KF et al., Sci Transl Med, 2011 3(108):108ra112
Kolonin MG et al., Nat Med, 2004 10(6):625–632
White JD et al., Int J Obes (Lond), 2013 37(12):1572–1579

Category:

OVERVIEW

Adipotide (FTPP) 10mg is an experimental peptide investigated for its potential role in targeted fat reduction. It is designed to bind to specific receptors found on the blood vessels that supply white adipose (fat) tissue. By attaching to these receptors, Adipotide may disrupt the blood flow to fat cells, leading to their breakdown and gradual reduction. Unlike traditional weight-loss supplements that focus on appetite suppression or metabolism stimulation, Adipotide works through a vascular-targeting mechanism. Early preclinical studies, particularly in animal models, showed reductions in body fat and improvements in metabolic markers.

However, Adipotide remains a research compound and is not approved by regulatory authorities such as the U.S. Food and Drug Administration for human use. Limited clinical data means its long-term safety, effectiveness, and appropriate dosing are not fully established. Reported concerns in early trials included potential kidney stress. Anyone considering peptide therapies should consult a qualified healthcare professional and rely on evidence-based medical guidance rather than experimental or unverified products.

Reviews

There are no reviews yet.

Be the first to review “Adipotide (FTPP) 10mg”

Your email address will not be published. Required fields are marked *

Shopping Cart